PSL Glass Filter Dryer - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

PSL Glass Filter Dryer

The GFD® is changing the filtration and drying process in laboratories worldwide. In 2010, the GFD technology was launched combining filtration, cake washing and drying all in one glass vessel.

Working as a miniature agitated nustche filter dryer, this technology allows laboratory development simulating the manufacturing process at a small scale. When the filtration and drying process is validated during R&D, direct scale up is possible first through the three different sizes of GFD then with industrial metallic vessel during pilot plant and commercial production.

In little more than the 3 years since launch over many companies have already adopted this technology worldwide. Applications range from API filtration, peptides washing and drying, simulation for future industrial application, filtration and drying of different deposits sensitive to air or moisture, and most recently microsphere filtration.

Microspheres are small spherical particles, having a required size range. These particles can be manufactured from various natural and synthetic materials such as polymer microspheres. Suspended microspheres obtained from various micro encapsulation processes require being washed, collected by filtration then dried under appropriate conditions to give the final free flowing injectable product. After the process development phase performed with a GFD, direct scale-up is available with PSL Microsphere Refiner product range.

Website: www.powdersystems.com
E-mail: saleseu@powdersystems.com
T: +44 (0)151 448 7700
Stand location: Hall 4.1 Stand J50

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
26%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
FindPharma Custom Search

Click here